These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 11503357)

  • 21. Economic evaluation of preventive programmes against congenital toxoplasmosis.
    Stray-Pedersen B; Jenum P
    Scand J Infect Dis Suppl; 1992; 84():86-96. PubMed ID: 1290083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Should a preventive congenital toxoplasmosis program be established in Switzerland?].
    Raeber PA
    Schweiz Med Wochenschr Suppl; 1995; 65():5S-9S. PubMed ID: 7716453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The Spanish Society of Pediatric Infectious Diseases Guidelines for the diagnosis and treatment of congenital toxoplasmosis].
    Baquero-Artigao F; del Castillo Martín F; Fuentes Corripio I; Goncé Mellgren A; Fortuny Guasch C; de la Calle Fernández-Miranda M; González-Tomé MI; Couceiro Gianzo JA; Neth O; Ramos Amador JT;
    An Pediatr (Barc); 2013 Aug; 79(2):116.e1-116.e16. PubMed ID: 23352717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Toxoplasma infestation: prevalence, risk of congenital infection and development in Geneva from 1973 to 1987].
    Bornand JE; Piguet JD
    Schweiz Med Wochenschr; 1991 Jan; 121(1-2):21-9. PubMed ID: 1990419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prevention of toxoplasmosis: observations on follow-up experience in France].
    Desmonts G
    Prog Clin Biol Res; 1985; 163B():333-7. PubMed ID: 3983162
    [No Abstract]   [Full Text] [Related]  

  • 26. Prevention of congenital toxoplasmosis.
    Thalhammer O
    Neuropadiatrie; 1973 Jul; 4(3):233-7. PubMed ID: 4800489
    [No Abstract]   [Full Text] [Related]  

  • 27. [Evaluation of the postnatal treatment efficacy in congenital toxoplasmosis identified by the newborn screening programme].
    Paul M; Jaworska A; Twardosz-Pawlik H; Szczapa J; Stefaniak J
    Wiad Parazytol; 2001; 47 Suppl 1():107-12. PubMed ID: 16897960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Toxoplasmosis in pregnancy with special emphasis on laboratory diagnosis].
    Sibalić D; Durković-Daković O; Bobić B
    Jugosl Ginekol Perinatol; 1990; 30(3-4):97-101. PubMed ID: 2273911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of toxoplasmosis in the pregnant mother and newborn child.
    Stray-Pedersen B
    Scand J Infect Dis Suppl; 1992; 84():23-31. PubMed ID: 1290070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Value of prevention of congenital toxoplasmosis].
    Douche C; Benabdesselam A; Mokhtari F; Le Mer Y
    J Fr Ophtalmol; 1996; 19(5):330-4. PubMed ID: 8762899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost effectiveness of a screen-and-treat program for asymptomatic vaginal infections in pregnancy: towards a significant reduction in the costs of prematurity.
    Kiss H; Pichler E; Petricevic L; Husslein P
    Eur J Obstet Gynecol Reprod Biol; 2006 Aug; 127(2):198-203. PubMed ID: 16303228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prevention of congenital toxoplasmosis in Europe].
    Raeber PA; Biedermann K; Just M; Zuber P
    Schweiz Med Wochenschr Suppl; 1995; 65():96S-102S. PubMed ID: 7716459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Congenital toxoplasmosis: epidemiologic features and control.
    Carter AO; Frank JW
    CMAJ; 1986 Sep; 135(6):618-23. PubMed ID: 3756692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Generalized neonatal screening based on laboratory tests].
    Ardaillou R; Le Gall JY
    Bull Acad Natl Med; 2006 Nov; 190(8):1745-59. PubMed ID: 17650757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxoplasmosis in pregnancy: an emerging concern for family physicians.
    Bakht FR; Gentry LO
    Am Fam Physician; 1992 Apr; 45(4):1683-90. PubMed ID: 1558044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Congenital toxoplasmosis in France in 2007: first results from a national surveillance system.
    Villena I; Ancelle T; Delmas C; Garcia P; Brezin AP; Thulliez P; Wallon M; King L; Goulet V;
    Euro Surveill; 2010 Jun; 15(25):. PubMed ID: 20587361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Serodiagnosis of toxoplasmosis developing during pregnancy and of congenital toxoplasmosis].
    Jeannel D; Niel G; Danis M; Gentilini M
    Rev Fr Gynecol Obstet; 1988 Mar; 83(3):133-6, 139-44. PubMed ID: 3285442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Routine CMV screening during pregnancy.
    Collinet P; Subtil D; Houfflin-Debarge V; Kacet N; Dewilde A; Puech F
    Eur J Obstet Gynecol Reprod Biol; 2004 May; 114(1):3-11. PubMed ID: 15099862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution of new techniques for the diagnosis of congenital toxoplasmosis.
    Robert-Gangneux F
    Clin Lab; 2001; 47(3-4):135-41. PubMed ID: 11294576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Preventive studies of congenital toxoplasmosis based on studies conducted in other countries].
    Rydzewski A
    Wiad Parazytol; 1988; 34(4-6):713-8. PubMed ID: 3242304
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.